Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZH3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,721
Award facts
- Contract value 100% obligated
- $12,720.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,720.92 to DMS Pharmaceutical Group Inc. for Jakafi 5 mg tablets (60-count units) on January 26, 2026, with an ultimate completion date of January 27, 2026. This firm fixed-price delivery order carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis. DMS Pharmaceutical Group Inc., headquartered in Park Ridge, Illinois, is a pharmaceutical wholesaler that has maintained active registration in the System for Award Management since 2001 and specializes in distributing prescription medications, over-the-counter drugs, biologics, and medical consumables to federal agencies, particularly the Department of Defense.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded on November 13, 2025, with a completion date of December 31, 2036. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to Department of Defense military healthcare facilities worldwide. The company's proven performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements supporting global military medical operations.
Quick answers
Who was awarded contract SPE2DR26FCZH3?
SPE2DR26FCZH3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FCZH3 worth?
The government has obligated $12,721 on SPE2DR26FCZH3.
Is contract SPE2DR26FCZH3 an order under another contract?
Yes. SPE2DR26FCZH3 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZH3 competed?
The extent of competition for SPE2DR26FCZH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award